Gentamek

Gentamek may be available in the countries listed below.

Ingredient matches for Gentamek

Gentamicin

Gentamicin is reported as an ingredient of Gentamek in the following countries:

• Peru

International Drug Name Search

Plaquenil

Plaquenil is a brand name of hydroxychloroquine, approved by the FDA in the following formulation(s):

PLAQUENIL (hydroxychloroquine sulfate - tablet; oral)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): 200MG ^[RLD][AB]

Has a generic version of Plaquenil been approved?

Yes. The following products are equivalent to Plaquenil:

hydroxychloroquine sulfate tablet; oral

• 
  Manufacturer: IPCA LABS LTD
  
  Approval date: June 14, 2007
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: May 29, 1998
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: November 30, 1995
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: January 27, 1996
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: September 30, 1994
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: November 30, 1995
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: WEST WARD
  
  Approval date: August 15, 2007
  
  Strength(s): 200MG ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: September 21, 2007
  
  Strength(s): 200MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Plaquenil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Plaquenil.

See also...

• Plaquenil Consumer Information (Drugs.com)
• Plaquenil Consumer Information (Wolters Kluwer)
• Plaquenil Sulfate Consumer Information (Cerner Multum)
• Plaquenil Advanced Consumer Information (Micromedex)
• Plaquenil AHFS DI Monographs (ASHP)
• Hydroxychloroquine Consumer Information (Wolters Kluwer)
• Hydroxychloroquine Consumer Information (Cerner Multum)
• Hydroxychloroquine Advanced Consumer Information (Micromedex)
• Hydroxychloroquine Sulfate AHFS DI Monographs (ASHP)

Movens

Movens may be available in the countries listed below.

Ingredient matches for Movens

Meclofenamic Acid

Meclofenamic Acid is reported as an ingredient of Movens in the following countries:

• Italy

International Drug Name Search

Tibolona

Tibolona may be available in the countries listed below.

Ingredient matches for Tibolona

Tibolone

Tibolone is reported as an ingredient of Tibolona in the following countries:

• Argentina

International Drug Name Search

Lormetazepam

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05CD06

CAS registry number (Chemical Abstracts Service)

0000848-75-9

Chemical Formula

C16-H12-Cl2-N2-O2

Molecular Weight

335

Therapeutic Categories

Benzodiazepine derivative

Hypnotic agent

Chemical Name

2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-

Foreign Names

• Lormetazepamum (Latin)
• Lormetazepam (German)
• Lormétazépam (French)
• Lormetazepam (Spanish)

Generic Names

• Lormetazepam (OS: BAN, USAN, JAN, DCIT)
• Lormétazépam (OS: DCF)
• Wy 4082 (IS: Wyeth)
• ZK 65997 (IS: Schering)
• Lormetazepam (PH: BP 2010)

Brand Names

• Aldosomnil
  Aldo Union, Spain



• Axilium
  B&G, Italy



• Doc Lormeta
  Docpharma, Luxembourg



• Doclormeta
  Docpharma, Belgium



• Ergocalm
  Teofarma, Germany



• Evamyl
  Bayer Yakuhin, Japan



• Ipnolor
  Krugher, Italy



• Loramet
  Akromed, South Africa; Aktuapharma, Belgium; Meda, Belgium; Meda, Switzerland; Meda, Luxembourg; Meda Pharma Sau, Spain; Wyeth, Greece; Wyeth, Luxembourg; Wyeth, Singapore; Wyeth KK, Japan



• Loranka
  SMB, Belgium; SMB, Luxembourg



• Loretam
  Valeant, Germany



• Lormetamed
  Ranbaxy, Belgium



• Lormetazepam A
  Apothecon, Netherlands



• Lormetazepam ABC
  ABC, Italy



• Lormetazepam acis
  Acis, Germany



• Lormetazepam Actavis
  Actavis, Italy; Actavis, Netherlands



• Lormetazepam AL
  Aliud, Germany



• Lormetazepam Almus
  Almus, Italy



• Lormetazepam Alter
  Alter, Italy



• Lormetazepam CF
  Centrafarm, Netherlands



• Lormetazepam Cinfa
  Cinfa, Spain



• Lormetazepam DOC
  DOC Generici, Italy



• Lormetazepam EG
  EG, Italy; Eurogenerics, Belgium



• Lormetazepam FLX
  Accord Healthcare, Netherlands



• Lormetazepam Germed
  Germed Pliva, Italy



• Lormetazepam Hexal
  Hexal, Italy



• Lormetazepam Katwijk
  Apotex Europe, Netherlands



• Lormetazepam Kela
  Kela, Belgium



• Lormetazepam Merck
  Mylan, Netherlands



• Lormetazepam Mylan
  Mylan, Italy



• Lormetazepam Normon
  Normon, Spain



• Lormetazepam PCH
  Pharmachemie, Netherlands



• Lormetazepam Ranbaxy
  Ranbaxy, Italy



• Lormetazepam ratiopharm
  Ratiopharm, Germany; Ratiopharm, Italy



• Lormetazepam Ratiopharm
  ratiopharm, Netherlands



• Lormetazepam Sandoz
  Sandoz, Italy; Sandoz, Netherlands



• Lormetazepam Sigma Tau
  Sigma Tau, Italy



• Lormetazepam Teva
  Teva, Belgium; Teva, Italy



• Lormetazepam Winthrop
  Winthrop, Italy



• Lormetazepam
  GenRx, Netherlands



• Lormetazepam-Eurogenerics
  Eurogenerics, Luxembourg



• Lormetazepam-Teva
  Teva, Germany



• Luzul
  Baldacci, Italy



• Metatop
  Apotex, Belgium



• Mexylor
  Epifarma, Italy



• Minias
  Bayer, Italy



• Noctacalm
  Socobom, Belgium; Socobom, Luxembourg



• Noctamid
  Aktuapharma, Belgium; Bayer, Austria; Bayer, Belgium; Bayer, Switzerland; Bayer, Germany; Bayer, Spain; Bayer, Netherlands; Bayer, New Zealand; Bayer Animal Health, Luxembourg; Bayer Schering, Ireland; Bayer Schering, South Africa; Schering, Malta



• Noctamide Orifarm
  Bayer Schering Pharma, Denmark



• Noctamide
  Bayer Santé, France



• Noctofer
  Polfa Tarchomin, Poland



• Nocton
  Saval Eurolab, Chile



• Octonox
  Pharmacobel, Belgium



• Pronoctan
  Bayer Schering Pharma, Denmark



• Sedaben
  Labima, Belgium



• Stilaze
  Nycomed, Belgium; Sandipro, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ibuprofeno Sant Gall Friburg

Ibuprofeno Sant Gall Friburg may be available in the countries listed below.

Ingredient matches for Ibuprofeno Sant Gall Friburg

Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Sant Gall Friburg in the following countries:

• Argentina

International Drug Name Search

Calcipotriol

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

D05AX02

CAS registry number (Chemical Abstracts Service)

0112828-00-9

Chemical Formula

C27-H40-O3

Molecular Weight

412

Therapeutic Category

Dermatological agent: Antipsoriatic

Chemical Names

(5Z,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3ß,24-triol (WHO)

9,10-Secochola-5,7,10,(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-,(1α,3beta,5Z,7E,22E,24S)- (USAN)

Foreign Names

• Calcipotriolum anhydricum (Latin)
• Calcipotriol, wasserfrei (German)
• Calcipotriol (French)
• Calcipotriol (Spanish)

Generic Names

• Calcipotriene (OS: USAN)
• Calcipotriol (OS: BAN, DCF)
• Calcipotriolo (OS: DCIT)
• BMS-181161 (IS)
• BMY-30434 (IS)
• MC 903 (IS: Leo)
• UNII-143NQ3779B (IS)
• Calcipotriol Anhydrous (PH: BP 2010)
• Calcipotriol, anhydrous (PH: BP 2007, Ph. Eur. 6)
• Calcipotriolum anhydricum (PH: Ph. Eur. 6)
• Calcipotriol Monohydrate (PH: Ph. Eur. 6, BP 2010)

Brand Names

• Calcipotriene
  Hi-Tech, United States; Nycomed, United States; Tolmar, United States



• Calcipotriol Hexal
  Hexal, Germany



• Calcipotriol Rafarm
  Rafarm, Greece



• Calcipotriol Sandoz
  Sandoz, Austria; Sandoz, Germany; Sandoz, Estonia; Sandoz, Latvia



• Calcipotriol
  Novartis Consumer Health, Netherlands; Pharmachemie, Netherlands; Sandoz, Netherlands



• Calcipotriol-1A Pharma
  1A Pharma, Germany



• Calcipotriolo Sandoz
  Sandoz, Italy



• Cipocal
  Pharmex, Greece



• Daivobet (Calcipotriol and Betamethasone)
  CSL, Australia; Darya-Varia, Indonesia; Leo, Norway; LEO Pharma, Denmark; LEO Pharma, Spain; LEO Pharma, Indonesia; Pharmagan, Slovenia



• Daivonex
  Andromaco, Argentina; Andromaco, Chile; CSL, Australia; Darya-Varia, Indonesia; Dr. Fisher, Netherlands; Euro, Netherlands; Formenti, Italy; Harvester, Taiwan; Leo, Bangladesh; Leo, Bulgaria; Leo, Bahrain; Leo, Switzerland; Leo, China; Leo, Costa Rica; Leo, Czech Republic; Leo, Dominican Republic; Leo, Estonia; Leo, Finland; Leo, France; Leo, Guatemala; Leo, Hong Kong; Leo, Honduras; Leo, Hungary; Leo, Israel; Leo, Iceland; Leo, Sri Lanka; Leo, Lithuania; Leo, Lithuania; Leo, Luxembourg; Leo, Latvia; Leo, Malta; Leo, Malaysia; Leo, Netherlands; Leo, Norway; Leo, New Zealand; Leo, Oman; Leo, Panama; Leo, Philippines; Leo, Poland; Leo, Portugal; Leo, Romania; Leo, Singapore; Leo, El Salvador; Leo, Thailand; Leo, Tunisia; Leo Pharma, Germany; Leo Pharma, Denmark; Leo Pharma, Spain; Leo Pharma, Indonesia; Leo Pharma, Vietnam; Nycomed, Russian Federation; Pharmagan, Slovenia; Roche, Colombia; Roche, Ecuador; Valeant, Mexico; Win-Medicare, India



• Dopotril
  Phoinix Pharm, Greece



• Dovobet (Calcipotriol and Betamethasone)
  Adcock Ingram Pharmaceuticals, South Africa; Leo, Canada; Leo, Greece; Leo Pharma, Luxembourg



• Dovonex
  Adcock Ingram Pharmaceuticals, South Africa; Leo, Canada; Leo, Greece; Leo, Ireland; Leo, United States; Leo Pharma, United Kingdom; Teikoku Seiyaku, Japan



• Eukadar
  Darier, Mexico



• F-Psorin
  Mediapharm, Greece



• Psoraffect
  Verisfield, Greece



• Psorcutan
  Intendis, Germany; Intendis, Italy; Intendis, Turkey



• Sorel
  Lek, Bosnia & Herzegowina; Lek, Poland; Lek, Romania; Lek, Slovenia



• Taclonex (Calcipotriol and Betamethasone)
  Leo, United States



• Xamiol (Calcipotriol and Betamethason)
  Leo Pharma, Luxembourg



• Daivobet (Calcipotriol and Betamethasone)
  Leo, Switzerland; Leo, Finland; Leo, France; Leo, Sweden



• Daivobet (Calcipotriol and Calcipotriol)
  Leo Pharma, Germany



• Daivonex
  Dr. Fisher, Netherlands; Euro, Netherlands; Leo, Belgium; Leo, Switzerland; Leo, Netherlands; Leo, Sweden



• Dovobet (Calcipotriol and Betamethasone)
  Formenti, Italy; Leo, Ireland; Leo, Netherlands; Leo Pharma, United Kingdom



• Psorcutan
  Intendis, Austria



• Psorcutan Beta (Calcipotriol and Betamethasone)
  Intendis, Germany



• Xamiol (Calcipotriol and Betamethason)
  Leo, Switzerland; Leo, France; Leo, Ireland; Leo, Sweden; Leo Pharma, Germany; Leo Pharma, United Kingdom

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Glizolan

Glizolan may be available in the countries listed below.

Ingredient matches for Glizolan

Diacerein

Diacerein is reported as an ingredient of Glizolan in the following countries:

• Spain

International Drug Name Search

Losartan Potasico Quilab

Losartan Potasico Quilab may be available in the countries listed below.

Ingredient matches for Losartan Potasico Quilab

Losartan

Losartan potassium salt (a derivative of Losartan) is reported as an ingredient of Losartan Potasico Quilab in the following countries:

• Peru

International Drug Name Search

Fluxacil

Fluxacil may be available in the countries listed below.

Ingredient matches for Fluxacil

Flucloxacillin

Flucloxacillin sodium salt (a derivative of Flucloxacillin) is reported as an ingredient of Fluxacil in the following countries:

• Italy

International Drug Name Search

Meclosorb

Meclosorb may be available in the countries listed below.

Ingredient matches for Meclosorb

Meclocycline

Meclocycline sulfosalicylate (a derivative of Meclocycline) is reported as an ingredient of Meclosorb in the following countries:

• Germany

International Drug Name Search

Stomatidin

Stomatidin may be available in the countries listed below.

Ingredient matches for Stomatidin

Cimetidine

Cimetidine is reported as an ingredient of Stomatidin in the following countries:

• Japan

Hexetidine

Hexetidine is reported as an ingredient of Stomatidin in the following countries:

• Bosnia & Herzegowina

International Drug Name Search

Navilox

Navilox may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Navilox

Isoxsuprine

Isoxsuprine hydrochloride (a derivative of Isoxsuprine) is reported as an ingredient of Navilox in the following countries:

• United Kingdom

International Drug Name Search

Benzoylperoxide PCH

Benzoylperoxide PCH may be available in the countries listed below.

Ingredient matches for Benzoylperoxide PCH

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Benzoylperoxide PCH in the following countries:

• Netherlands

International Drug Name Search

Metoprolol Actavis

Metoprolol Actavis may be available in the countries listed below.

Ingredient matches for Metoprolol Actavis

Metoprolol

Metoprolol succinate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol Actavis in the following countries:

• Sweden

International Drug Name Search

Alertec

Alertec may be available in the countries listed below.

Ingredient matches for Alertec

Modafinil

Modafinil is reported as an ingredient of Alertec in the following countries:

• Canada

International Drug Name Search

Noxyflex S

Noxyflex S may be available in the countries listed below.

Ingredient matches for Noxyflex S

Noxytiolin

Noxytiolin is reported as an ingredient of Noxyflex S in the following countries:

• Ireland


• United Kingdom

International Drug Name Search

Metildigoxin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01AA08

CAS registry number (Chemical Abstracts Service)

0030685-43-9

Chemical Formula

C42-H66-O14

Molecular Weight

794

Therapeutic Category

Cardiac glycoside

Chemical Names

(3ß,5ß,12ß)-3-[(O-2,6-Dideoxy-4-O-methyl-ß-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-ß-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-ß-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolid (IUPAC)

4'''-O-Methyldigoxin (WHO)

Foreign Names

• Metildigoxinum (Latin)
• Metildigoxin (German)
• Métildigoxine (French)
• Metildigoxina (Spanish)

Generic Names

• Medigoxin (OS: BAN)
• Metildigossina (OS: DCIT)
• Metildigoxin (OS: BAN)
• beta-Methyl-digoxin (IS)
• Metildigoxin (PH: JP XIV)

Brand Names

• Bemecor
  Lek, Poland



• Dimekor
  Galenika, Serbia



• Lanirapid
  Chugai, Japan; Kern, Spain



• Lanitop
  Adienne, Italy; EuroCept, Belgium; IL-CSM, Bulgaria; Pliva, Croatia (Hrvatska); Pliva, Slovenia; Riemser, Austria; Riemser, Botswana; Riemser, Chile; Riemser, Czech Republic; Riemser, Germany; Riemser, Ghana; Riemser, Greece; Riemser, Hong Kong; Riemser, Kenya; Riemser, Luxembourg; Riemser, Mauritius; Riemser, Malawi; Riemser, Namibia; Riemser, Nigeria; Riemser, Portugal; Riemser, Sudan; Riemser, Tanzania; Riemser, Uganda; Riemser, Zambia; Riemser, Zimbabwe; Vargas, Venezuela



• Medigox
  Polfa Warszawa, Poland

International Drug Name Search

Glossary

BAN	British Approved Name
DCIT	Denominazione Comune Italiana
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Glirid

Glirid may be available in the countries listed below.

Ingredient matches for Glirid

Glimepiride

Glimepiride is reported as an ingredient of Glirid in the following countries:

• Greece


• Turkey

International Drug Name Search

Nicotinell comprimé à sucer sans sucre

Nicotinell comprimé à sucer sans sucre may be available in the countries listed below.

Ingredient matches for Nicotinell comprimé à sucer sans sucre

Nicotine

Nicotine resinate (a derivative of Nicotine) is reported as an ingredient of Nicotinell comprimé à sucer sans sucre in the following countries:

• France

International Drug Name Search

Acecomb

Acecomb may be available in the countries listed below.

Ingredient matches for Acecomb

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Acecomb in the following countries:

• Austria

Lisinopril

Lisinopril is reported as an ingredient of Acecomb in the following countries:

• Austria

International Drug Name Search

Apo-Quinine

Apo-Quinine may be available in the countries listed below.

Ingredient matches for Apo-Quinine

Quinine

Quinine sulfate (a derivative of Quinine) is reported as an ingredient of Apo-Quinine in the following countries:

• Canada

International Drug Name Search

Fortecortin

Fortecortin may be available in the countries listed below.

Ingredient matches for Fortecortin

Dexamethasone

Dexamethasone is reported as an ingredient of Fortecortin in the following countries:

• Austria


• Czech Republic


• Germany


• Luxembourg


• Switzerland

Dexamethasone 21-(disodium phosphate) (a derivative of Dexamethasone) is reported as an ingredient of Fortecortin in the following countries:

• Austria


• Germany


• Switzerland

International Drug Name Search

Gelofusine

Gelofusine may be available in the countries listed below.

Ingredient matches for Gelofusine

Gelatin

Gelatin succinylated (a derivative of Gelatin) is reported as an ingredient of Gelofusine in the following countries:

• Australia


• Austria


• Estonia


• Finland


• Italy


• Luxembourg


• Myanmar


• New Zealand


• Slovenia


• South Africa


• Sweden


• Turkey

International Drug Name Search

Isosorbide mononitraat Euro

Isosorbide mononitraat Euro may be available in the countries listed below.

Ingredient matches for Isosorbide mononitraat Euro

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Isosorbide mononitraat Euro in the following countries:

• Netherlands

International Drug Name Search

Hidermart

Hidermart may be available in the countries listed below.

Ingredient matches for Hidermart

Enoxolone

Enoxolone is reported as an ingredient of Hidermart in the following countries:

• Japan

International Drug Name Search

Lormetazepam Sandoz

Lormetazepam Sandoz may be available in the countries listed below.

Ingredient matches for Lormetazepam Sandoz

Lormetazepam

Lormetazepam is reported as an ingredient of Lormetazepam Sandoz in the following countries:

• Italy


• Netherlands

International Drug Name Search

Cefaclor

In the US, Cefaclor (cefaclor systemic) is a member of the drug class second generation cephalosporins and is used to treat Bladder Infection, Bronchitis, Kidney Infections, Otitis Media, Pneumonia, Sinusitis, Skin and Structure Infection, Skin Infection, Tonsillitis/Pharyngitis, Upper Respiratory Tract Infection and Urinary Tract Infection.

US matches:

• Cefaclor


• Cefaclor Capsules


• Cefaclor Extended-Release Tablets


• Cefaclor Suspension


• Cefaclor Extended Release Tablets

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DC04

CAS registry number (Chemical Abstracts Service)

0053994-73-3

Chemical Formula

C15-H14-Cl-N3-O4-S

Molecular Weight

367

Therapeutic Category

Antibacterial: Cephalosporin, cephalosporinase-sensitive

Chemical Name

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[(aminophenylacetyl)amino]-3-chloro-8-oxo-, [6R-[6α,7ß(R*)]]-

Foreign Names

• Cefaclorum (Latin)
• Cefaclor (German)
• Cefaclor (French)
• Cefaclor (Spanish)

Generic Names

• Cefaclor (OS: USAN, JAN, BAN)
• Cefacloro (OS: DCIT)
• Céfeaclor (OS: DCF)
• Cephaclor (IS: ASK)
• Compound 99638 (IS: Lilly)
• Cefaclor (PH: USP 32)
• Cephaclor-1-Wasser (IS: ASK)
• S 6472 (IS)
• Cefaclor (PH: BP 2010, JP XV, USP 30, Ph. Eur. 6)
• Céfaclor (PH: Ph. Eur. 6)
• Cefaclor-Monohydrat (PH: Ph. Eur. 6)
• Cefaclorum (PH: Ph. Eur. 6)

Brand Names

• Afecton
  Help, Greece



• Alenfral
  Choseido Pharmaceutical, Japan



• Alfacet
  Galenika, Serbia



• Apo-Cefaclor
  Apotex, Canada; Apotex, Guyana; Apotex, Vietnam



• Axcel Cefaclor
  Kotra, Myanmar



• Bearclor
  Daewoong, Vietnam



• Camirox
  Norma, Greece



• Capabiotic
  Fahrenheit, Indonesia



• CCL
  Nichi-Iko PharmaceuticalJMA, Japan



• Ceclodan
  Taiyo Pharmaceutical, Japan



• Ceclor
  Actavis, Bosnia & Herzegowina; Altana, Mexico; Cipa, Peru; Eli Lilly, Oman; Eli Lilly and Company, Ethiopia; Lilly, Bahrain; Lilly, Greece; Lilly, Hungary; Lilly, Israel; Lilly, Kenya; Lilly, Sri Lanka; Lilly, Russian Federation; Lilly, Slovenia; Lilly, Tanzania; Lilly, Uganda; Medinfar, Portugal; Sigma-Tau, Switzerland; Spimaco, Oman; Teva, Poland



• Ceclozone MR
  Ozone Laboratories, Romania



• Cedoclor
  Hawon, Vietnam



• Cefabac
  APM, United Arab Emirates; APM, Iraq; APM, Jordan; APM, Kuwait; APM, Lebanon; APM, Libya; APM, Nigeria; APM, Qatar; APM, Saudi Arabia; APM, Sudan; APM, Syria; APM, Yemen; Arab Pharmaceutical Manufacturing, Bahrain; Pharmalab, Peru; Pharmalab, Peru



• Cefaclor Alkaloid
  Alkaloid, Bulgaria



• Cefaclor Bidiphar
  Bidiphar, Vietnam



• Cefaclor Domesco
  Domesco, Vietnam



• Cefaclor Generis
  Generis, Portugal



• Cefaclor MK
  Bonima, Costa Rica; Bonima, Guatemala; Bonima, Nicaragua; Bonima, Panama; Bonima, El Salvador; MK Pharmaceuticals, Jamaica



• Céfaclor Mylan
  Mylan, France



• Céfaclor RPG
  RPG, France



• Cefaclor Stada
  PMP, Vietnam



• Cefaclor Uphace
  Uphace, Vietnam



• Cefaclor
  Alkaloid, Serbia; Carlsbad, United States; Ceph, United States; Europharm, Romania; Farmindustria, Peru; Hemofarm, Serbia; Iqfarma, Peru; Marsam, United States; Ozone Laboratories, Romania; Par, United States; Ranbaxy, United States; Remevita, Serbia; Synpac, Taiwan; Teva USA, United States



• Cefaclor-Baker Norton
  Kunming Baker Norton, China



• Cefacloril
  Remek, Greece



• Cefaclor-Teva
  Teva, Israel



• Cefaklon
  Klonal, Argentina



• Cefaklor
  Hemofarm, Romania; Hemofarm, Serbia; Medis, Slovenia



• Cefalan
  Merck, Mexico



• Cefalon
  L.B.S., Vietnam



• Cefalor
  Vitamed, Israel



• Cefcor
  Ranbaxy, Peru



• Cephlor
  Shiba, Yemen



• Cero
  Taiwan Biotech, Taiwan



• Cleancef
  Shin Poong, Singapore



• Cloracef
  Dar-Al-Dawa, United Arab Emirates; Dar-Al-Dawa, Bahrain; Dar-Al-Dawa, Iraq; Dar-Al-Dawa, Jordan; Dar-Al-Dawa, Kuwait; Dar-Al-Dawa, Lebanon; Dar-Al-Dawa, Libya; Dar-Al-Dawa, Nigeria; Dar-Al-Dawa, Oman; Dar-Al-Dawa, Qatar; Dar-Al-Dawa, Romania; Dar-Al-Dawa, Saudi Arabia; Dar-Al-Dawa, Sudan; Dar-Al-Dawa, Somalia; Dar-Al-Dawa, Yemen; Ethica Industri Farmasi, Indonesia



• Clorad
  ACS, Italy



• Distaclor
  Clonmel, Ireland; Lilly, India



• Ericanal
  Towa Yakuhin, Japan



• Ericanal L
  Towa Yakuhin, Japan



• Forticef
  Ram Pharmaceutical, Oman



• Fredyren
  Rafarm, Greece



• Infectocef
  Infectopharm, Germany



• Keflor
  Ranbaxy, China; Ranbaxy, India; Ranbaxy, Sri Lanka



• Kefpolin
  Sawai Seiyaku, Japan



• Kefral
  Shionogi Seiyaku, Japan



• Keftid
  Galen, Ireland



• Kulilel
  Tatsumi Kagaku, Japan



• L-CCL
  Nichi-Iko PharmaceuticalJMA, Japan



• L-Kefral
  Shionogi Seiyaku, Japan



• Losefar
  Eczacibasi, Turkey



• Medoclor
  Medochemie, Hong Kong; Medochemie, Romania



• Mekocefaclor
  Mekophar, Vietnam



• Nockwoo Cefaclor
  Welfide, Vietnam



• Opeclor
  O.P.V., Vietnam



• Panclor
  Elpen, Greece; Polfa Grodzisk, Poland



• Pharex Cefaclor
  Pascual, Philippines



• Pinaclor
  Pinewood, Ireland



• Qualiphor
  Quality, Hong Kong



• Ranbaxy Cefaclor
  Douglas, New Zealand



• Raniclor
  Pedinol, United States



• Recocef
  Julphar, Oman



• Rolfec
  Tai Yu, Taiwan



• Saltskural
  Shiono Kemikaru, Japan



• Soclor
  Soho, Indonesia



• Syntoclor
  Codal Synto, Sri Lanka



• Tabiclor
  Tabuk Pharmaceutical, Oman



• Tokiclor
  Isei, Japan



• Ufoxilin
  Proel, Greece



• Vercef MR
  Ranbaxy, Hungary



• Vercef
  Ranbaxy, Hong Kong; Ranbaxy, Oman; Ranbaxy, Poland; Ranbaxy, Singapore; Ranbaxy, Slovakia; Ranbaxy, South Africa



• Aclor
  Aspen, Australia



• Afecton
  Help, Greece



• Alfatil
  Dexo, France



• Altaclor
  CT, Italy



• Bacticef
  Mitim, Italy



• Bactigram
  Magis, Italy



• Biocef
  Novartis, Bangladesh



• Bixelor-C
  Bruluagsa, Mexico



• Cadicefaclor
  Cagipharm, Vietnam



• Castal
  Apotec, Hong Kong



• Cec Hexal
  Hexal, Austria; Hexal, Romania



• Cec
  Basel, Turkey; Hexal, Germany; Hexal, Luxembourg; Rowe, Dominican Republic; Salutas Pharma, Bulgaria



• Ceclocare
  Pharmacara, Oman; Pharmacare, Bahrain



• Ceclodyne
  Lek, Romania



• Ceclor CD
  Lilly, Bangladesh



• Ceclor MR
  Lilly, Hong Kong; Lilly, Romania; Lilly, Slovenia; Lilly, Turkey



• Ceclor
  Altana, Mexico; Arcana, Austria; Aspen, Australia; Astro, Austria; EuroCept, Netherlands; Farma, Venezuela; GlaxoSmithKline, Philippines; Grupo Farma, Colombia; Inovail, Vietnam; Lilly, Bangladesh; Lilly, Czech Republic; Lilly, Greece; Lilly, Hong Kong; Lilly, Hungary; Lilly, Luxembourg; Lilly, Turkey; Madaus, Spain; Phadisco, Malta



• Ceclorbeta
  Betapharm, Germany



• Cefaclor acis
  Acis, Germany



• Cefaclor AL
  Aliud, Czech Republic; Aliud, Germany



• Cefaclor Basics
  Basics, Germany



• Cefaclor beta
  Betapharm, Germany



• Cefaclor Bexal
  Bexal, Spain



• Cefaclor DOC
  DOC Generici, Italy



• Cefaclor Domesco
  Domesco, Vietnam



• Cefaclor EG
  EG, Italy



• Cefaclor Germed
  Germed Pliva, Italy



• Cefaclor K24
  K24, Italy



• Cefaclor Labesfal
  Labesfal, Portugal



• Cefaclor Normon
  Normon, Spain



• Cefaclor Ranbaxy
  Ranbaxy, Spain



• Cefaclor ratiopharm
  Ratiopharm, Italy



• Cefaclor Sandoz
  Sandoz, Australia; Sandoz, Germany; Sandoz, Italy



• Cefaclor Stada
  Stada, Germany



• Cefaclor
  CCPC, Taiwan; Sandoz, Netherlands; Zentiva, Czech Republic



• Cefaclor-1A Pharma
  1A Pharma, Germany



• Cefaclor-CT
  CT Arzneimittel, Germany



• Cefaclor-GA
  Genepharm, Australia



• Cefaclor-ratiopharm
  Ratiopharm, Germany



• Cefaclor-Wolff
  Wolff, Germany



• Cefager
  Gerard, Ireland



• Cefalan
  Merck, Mexico



• Cefalor
  Apotec, Hong Kong



• Cefastad
  Stada, Austria



• Cef-Diolan
  Meda, Germany



• Ceflacid
  Collins, Mexico



• Ceflon
  Eskayef, Bangladesh



• Cefticlor
  Renata, Bangladesh



• Clocef
  Amico, Bangladesh



• Clorazer
  ACS, Italy



• Distaclor
  Flynn, United Kingdom; Lilly, Thailand



• Doccefaclo
  Docpharma, Belgium; Ranbaxy, Luxembourg



• Douglas Cefaclor CD
  Genepharm, Australia



• Eurocefix
  Alta Care, Malta



• Fasiclor
  Maver, Mexico



• Forifek
  Caprifarmindo, Indonesia



• Geniclor
  B&G, Italy



• GenRX Cefaclor
  Apotex, Australia



• Haxifal
  Erempharma, France



• hefa clor
  Suiphar, Dominican Republic



• Karlor
  Lennon Healthcare, Australia



• Kefcin
  HG.Pharm, Vietnam



• Keflor
  Alphapharm, Australia



• Kefolor
  Actavis, Finland



• Kefsid
  Fako, Turkey



• Kliacef
  So.Se., Italy



• Kloracef
  Bioton, Poland



• Lafarclor
  Lafare, Italy



• Loracef
  Square, Bangladesh



• Macovan
  Medifarma, Italy



• Makovan
  Medimar, Greece



• Medacef
  Medpharma, Oman



• Midocef
  Middle East, Oman



• Navacef
  Navana, Bangladesh



• Necloral
  New Research, Italy



• Oralcef
  Geymonat, Italy



• Oticlor
  Incepta, Bangladesh



• Ozcef
  Ranbaxy, Australia



• Panacef
  Valeas, Italy



• Panoral
  Eberth, Germany



• Performer
  Piam, Italy; Vecchi & Piam, Malta



• Phacotrex
  Bros, Greece



• Qualiceclor
  Quality, Hong Kong



• Remeclor
  Remedica, Cyprus



• Ritemed Cefaclor
  Ritemed, Philippines



• Sanocef
  Sanovel, Turkey



• Sefalor
  Techno, Bangladesh



• Selviclor
  SF, Italy



• Serviclor
  Sandoz, Czech Republic; Sandoz, Mexico



• Sifaclor
  Siam Bheasach, Thailand



• Soficlor
  Xepa-Soul, Myanmar; Xepa-Soul Pattinson, Hong Kong; Xepa-Soul Pattinson, Singapore



• Takecef
  Sofar, Italy



• Tibifor
  Lisapharma, Italy



• U-Clor
  U-Liang, Taiwan



• Valeclor
  Epifarma, Italy



• Vercef MR
  Ranbaxy, Czech Republic; Ranbaxy, Romania



• Vercef
  Ranbaxy, Czech Republic; Ranbaxy, Hungary; Ranbaxy, Romania; Ranbaxy, Slovakia



• Xelent
  Westmont, Philippines

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Facelit

Facelit may be available in the countries listed below.

Ingredient matches for Facelit

Cefalexin

Cefalexin hydrochloride (a derivative of Cefalexin) is reported as an ingredient of Facelit in the following countries:

• Mexico

International Drug Name Search

Itraconazol Farmindustria

Itraconazol Farmindustria may be available in the countries listed below.

Ingredient matches for Itraconazol Farmindustria

Itraconazole

Itraconazole is reported as an ingredient of Itraconazol Farmindustria in the following countries:

• Peru

International Drug Name Search

Epinastine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R06AX24,S01GX10

CAS registry number (Chemical Abstracts Service)

0080012-43-7

Chemical Formula

C16-H15-N3

Molecular Weight

249

Therapeutic Category

Histamine, H₁-receptor antagonist

Chemical Name

3-Amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine

Foreign Names

• Epinastinum (Latin)
• Epinastin (German)
• Epinastine (French)
• Epinastina (Spanish)

Generic Names

• Epinastine hydrochloride (OS: JAN)
• WAL 801 Cl (IS: Boehringer Ingelheim)

Brand Names

• Epioftal
  Farmindustria, Peru



• Purivist
  Allergan, France



• Relestat
  Abdi Ibrahim, Turkey



• Alegain
  Kyorin Rimedio, Japan



• Alenapion
  Choseido Pharmaceutical, Japan



• Aleroff
  Nichi-Iko PharmaceuticalJMA, Japan



• Alesion
  Boehringer Ingelheim, Japan



• Alesiotec
  Nihon Yakuhin Kogyo, Japan



• Alket
  Poen, Argentina



• Allernothin
  Morishita Jintan, Japan



• Alpeed
  Daito, Japan



• Aplatin
  Taiyo Pharmaceutical, Japan



• Asmot
  Tatsumi Kagaku, Japan



• Azusaleon
  Shiono Kemikaru, Japan



• Bellgfolm
  Isei, Japan



• Elestat
  Allergan, United States; Inspire, United States



• Elpinan
  Towa Yakuhin, Japan



• Epinastine
  Kotobuki Seiyaku, Japan



• Epinazion
  Medisa Shinyaku, Japan



• Flurinol
  Boehringer Ingelheim, Argentina; Boehringer Ingelheim, Chile; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Peru; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, Venezuela



• Helvottz
  Yoshindo, Japan



• Medejion
  Nipro GenephaNipurojenefa, Japan



• Pinasion
  Taisho Yakuhin, Japan



• Purivist
  Allergan, Czech Republic; Allergan, Slovakia



• Relestat
  Allergan, Austria; Allergan, Belgium; Allergan, Switzerland; Allergan, Spain; Allergan, United Kingdom; Allergan, Hungary; Allergan, Ireland; Allergan, Israel; Allergan, Italy; Allergan, Luxembourg; Allergan, Portugal; Allergan, Sweden; Allergan, Taiwan; GlaxoSmithKline, Poland; Pharm Allergan, Germany; Sanofi-Aventis, Ireland; Allergan South AfricaPty Ltd., South Africa



• Talerc
  Boehringer Ingelheim, Brazil



• Timkent
  Nisshin Seiyaku - Yamagata, Japan



• Yupitel
  Iwaki Seiyaku, Japan

International Drug Name Search

Glossary

IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Linoten

Linoten may be available in the countries listed below.

Ingredient matches for Linoten

Pamidronic Acid

Pamidronic Acid disodium salt (a derivative of Pamidronic Acid) is reported as an ingredient of Linoten in the following countries:

• Spain

International Drug Name Search

Glaveral

Glaveral may be available in the countries listed below.

Ingredient matches for Glaveral

Omeprazole

Omeprazole is reported as an ingredient of Glaveral in the following countries:

• Greece


• Romania

Omeprazole sodium salt (a derivative of Omeprazole) is reported as an ingredient of Glaveral in the following countries:

• Greece

International Drug Name Search

Nas

Nas may be available in the countries listed below.

Ingredient matches for Nas

Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Nas in the following countries:

• Venezuela

International Drug Name Search

Demex

Demex may be available in the countries listed below.

Ingredient matches for Demex

Propyphenazone

Propyphenazone is reported as an ingredient of Demex in the following countries:

• Germany

International Drug Name Search

Sapilent

Sapilent may be available in the countries listed below.

Ingredient matches for Sapilent

Trimipramine

Trimipramine is reported as an ingredient of Sapilent in the following countries:

• Hungary

International Drug Name Search

Optaflexx

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Optaflexx

Monensin

Monensin sodium salt (a derivative of Monensin) is reported as an ingredient of Optaflexx in the following countries:

• United States

Ractopamine

Ractopamine hydrochloride (a derivative of Ractopamine) is reported as an ingredient of Optaflexx in the following countries:

• United States

International Drug Name Search

BMD

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for BMD

Amprolium

Amprolium is reported as an ingredient of BMD in the following countries:

• United States

Bacitracin

Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of BMD in the following countries:

• New Zealand


• South Africa


• United States

Chlortetracycline

Chlortetracycline is reported as an ingredient of BMD in the following countries:

• United States

Chlortetracycline calcium salt (a derivative of Chlortetracycline) is reported as an ingredient of BMD in the following countries:

• United States

Chlortetracycline hydrochloride (a derivative of Chlortetracycline) is reported as an ingredient of BMD in the following countries:

• United States

Clopidol

Clopidol is reported as an ingredient of BMD in the following countries:

• United States

Decoquinate

Decoquinate is reported as an ingredient of BMD in the following countries:

• United States

Diclazuril

Diclazuril is reported as an ingredient of BMD in the following countries:

• United States

Dinitolmide

Dinitolmide is reported as an ingredient of BMD in the following countries:

• United States

Fenbendazole

Fenbendazole is reported as an ingredient of BMD in the following countries:

• United States

Halofuginone

Halofuginone hydrobromide (a derivative of Halofuginone) is reported as an ingredient of BMD in the following countries:

• United States

Ivermectin

Ivermectin is reported as an ingredient of BMD in the following countries:

• United States

Lasalocid

Lasalocid is reported as an ingredient of BMD in the following countries:

• United States

Monensin

Monensin is reported as an ingredient of BMD in the following countries:

• United States

Monensin sodium salt (a derivative of Monensin) is reported as an ingredient of BMD in the following countries:

• United States

Narasin

Narasin is reported as an ingredient of BMD in the following countries:

• United States

Nicarbazin

Nicarbazin is reported as an ingredient of BMD in the following countries:

• United States

Nitarsone

Nitarsone is reported as an ingredient of BMD in the following countries:

• United States

Robenidine

Robenidine hydrochloride (a derivative of Robenidine) is reported as an ingredient of BMD in the following countries:

• United States

Salinomycin

Salinomycin sodium salt (a derivative of Salinomycin) is reported as an ingredient of BMD in the following countries:

• United States

Semduramicin

Semduramicin sodium salt (a derivative of Semduramicin) is reported as an ingredient of BMD in the following countries:

• United States

International Drug Name Search

Estronorm

Estronorm may be available in the countries listed below.

Ingredient matches for Estronorm

Estradiol

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estronorm in the following countries:

• Germany

International Drug Name Search

Bevispas

Bevispas may be available in the countries listed below.

Ingredient matches for Bevispas

Mebeverine

Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Bevispas in the following countries:

• South Africa

International Drug Name Search

Pharken

Pharken may be available in the countries listed below.

Ingredient matches for Pharken

Pergolide

Pergolide mesilate (a derivative of Pergolide) is reported as an ingredient of Pharken in the following countries:

• Spain

International Drug Name Search

Omnitrope

Pronunciation: SOE-ma-TROE-pin
Generic Name: Somatropin (rDNA origin - Refrigerated)
Brand Name: Omnitrope

Omnitrope is used for:

Treating certain children or adults whose bodies do not produce enough growth hormone. It may also be used for other conditions as determined by your doctor.

Omnitrope is a growth hormone. It works by stimulating growth in patients who do not make enough natural growth hormone.

Do NOT use Omnitrope if:

• you are allergic to any ingredient in Omnitrope


• you have active or recurring cancer, a brain tumor, or other unusual growths


• you have severe breathing problems (eg, respiratory failure) or serious illness caused by complications from surgery or injury


• you have a certain type of eye problem caused by diabetes (diabetic retinopathy)


• the patient is a child who has Prader-Willi syndrome and is severely overweight or has severe breathing problems (eg, airway blockage, respiratory infection, sleep apnea)


• the patient is a child who has epiphyseal closure (bone growth is complete)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Omnitrope:

Some medical conditions may interact with Omnitrope. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of kidney problems, lung or breathing problems (eg, airway blockage, sleep apnea), an underactive thyroid, heart problems, or endocrine problems (eg, pituitary or adrenal gland problems)


• if you have a history of diabetes or high blood sugar levels, or if a member of your family has had diabetes


• if you have a history of leukemia, other types of cancer, or any unusual growths or tumors (especially in the brain)


• if you have curvature of the spine (scoliosis) or Prader-Willi syndrome


• if you are very overweight or have had recent major surgery or injury

Some MEDICINES MAY INTERACT with Omnitrope. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Corticosteroids (eg, prednisone) or estrogens because they may decrease Omnitrope's effectiveness


• Anticonvulsants (eg, carbamazepine) or cyclosporine because the risk of their side effects may be increased by Omnitrope


• Insulin or other medicines for diabetes because their effectiveness may be decreased by Omnitrope

This may not be a complete list of all interactions that may occur. Ask your health care provider if Omnitrope may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Omnitrope:

Use Omnitrope as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Omnitrope. Talk to your pharmacist if you have questions about this information.


• Omnitrope is given as an injection under the skin. A health care provider will teach you how to use it. Be sure you understand how to use Omnitrope. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• Do NOT shake Omnitrope.


• Omnitrope should be clear and colorless. Do not use Omnitrope if it contains particles, is cloudy or discolored, or if the container is cracked or damaged.


• Omnitrope may be injected in the thigh, buttocks, or abdomen. Be sure to rotate your injection site as directed to help avoid thickening or hardening of the skin.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Omnitrope, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Omnitrope.

Important safety information:

• Pancreas inflammation (pancreatitis) has been reported rarely in patients who take Omnitrope. The risk may be greater in children, especially in girls who have Turner syndrome. Contact your doctor right away if you develop stomach or back pain.


• Rarely, children using Omnitrope have experienced a slipped growth plate in the hip. Contact the doctor right away if the patient develops hip or knee pain or a limp.


• Diabetes patients - Omnitrope may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Lab tests, including blood sugar levels and thyroid function, may be performed while you use Omnitrope. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Omnitrope with caution in the ELDERLY; they may be more sensitive to its effects.


• Omnitrope may have benzyl alcohol in it. Do not use it in NEWBORNS or INFANTS. It may cause serious and sometimes fatal nervous system problems and other side effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Omnitrope while you are pregnant. It is not known if Omnitrope is found in breast milk. If you are or will be breast-feeding while you use Omnitrope, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Omnitrope:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Headache; mild swelling (eg, of the hands or feet); muscle or joint pain; prickling sensation of the skin; redness or itching at the injection site.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); burning, tingling, itching, or numbness in the palm of the hand, fingers, or wrist; change in appearance or size of a mole; hip or knee pain; limp; nausea or vomiting; new growth on the skin; severe or persistent stomach or back pain; severe or persistent swelling of the hands, ankles, or feet; sudden, severe, or persistent headache; symptoms of high blood sugar (eg, increased thirst, hunger, or urination; unusual weakness); thickened or hardened skin at the injection site; unusual bruising; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Omnitrope side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include dizziness; excessive thirst or hunger; fainting; fast heartbeat; frequent urination; swelling of the ankles, feet, or hands.

Proper storage of Omnitrope:

Store cartridges in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Protect from light. Do not use Omnitrope past the expiration date on the product label.

For the 5 mg/1.5 mL cartridge: After first use, store Omnitrope in the refrigerator for up to 3 weeks (21 days). Throw away any unused medicine after 3 weeks.

For the 10 mg/1.5 mL cartridge: After first use, store Omnitrope in the refrigerator for up to 4 weeks (28 days). Throw away any unused medicine after 4 weeks.

General information:

• If you have any questions about Omnitrope, please talk with your doctor, pharmacist, or other health care provider.


• Omnitrope is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Omnitrope. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Omnitrope resources

• Omnitrope Side Effects (in more detail)
• Omnitrope Use in Pregnancy & Breastfeeding
• Omnitrope Drug Interactions
• Omnitrope Support Group
• 0 Reviews for Omnitrope - Add your own review/rating

Compare Omnitrope with other medications

• Adult Human Growth Hormone Deficiency
• Pediatric Growth Hormone Deficiency
• Short Stature for Age

Nitrofural

In some countries, this medicine may only be approved for veterinary use.

Scheme

Prop.INN

ATC (Anatomical Therapeutic Chemical Classification)

B05CA03,D08AF01,D09AA03,P01CC02,S01AX04,S02AA02

CAS registry number (Chemical Abstracts Service)

0000059-87-0

Chemical Formula

C6-H6-N4-O4

Molecular Weight

198

Therapeutic Categories

Dermatological agent: Topical antiseptic

Antibacterial: Nitrofuran-derivative

Chemical Name

Hydrazinecarboxamide, 2-[(5-nitro-2-furanyl)methylene]-

Foreign Names

• Nitrofuralum (Latin)
• Nitrofural (German)
• Nitrofural (French)
• Nitrofural (Spanish)

Generic Names

• Nitrofural (OS: DCF, DCIT)
• Nitrofurazone (OS: BAN)
• F 6 (IS)
• Furacilinum (IS)
• Furaldone (IS)
• NF 7 (IS)
• Nitrofural (PH: Ph. Eur. 6)
• Nitrofuralum (PH: Ph. Eur. 6)
• Nitrofurazone (PH: BP 2010, USP 32)

Brand Names

• Bactazon
  ACPC - Arab Center for Pharmaceutical and Chemical, Oman; Arab Centre, Bahrain



• Bioderm (Nitrofural and Neomycin, + Prednisolone (veterinary use))
  Bomac, New Zealand



• Demodek
  Drag Pharma, Chile



• Dermofurin
  Ethical, Dominican Republic



• Fura Septin (veterinary use)
  Cross Vetpharm, United States



• Fura Zone (veterinary use)
  Squire, United States



• Fura (veterinary use)
  Farnam, United States



• Furacin
  Boehringer Ingelheim, Chile; Boehringer Ingelheim, Colombia; Eczacibasi, Turkey; Farma, Venezuela; GlaxoSmithKline, India; Medifarma, Peru; Norgine, Luxembourg; Riemser, Germany; Schering, Brazil; Schering-Plough, Argentina; Seid, Spain; Siegfried, Mexico



• Furacine
  Limacom, Belgium; Limacom, Luxembourg



• Furaderm
  Toprak, Turkey



• Furasep
  Beximco, Bangladesh



• Furatsiliinpiiritus
  Galenos, Estonia



• Furex
  Aspen Pharmacare, South Africa



• Furfuril
  Roemmers, Venezuela



• Furotricina (Nitrofural and Tyrothricin)
  Finderm, Italy



• Fuxal
  Cafar, Venezuela



• Hantina
  Apsen, Brazil



• Kufro
  Andromaco, Mexico



• NFZ (veterinary use)
  Hess & Clark, United States



• Nitrofurazon
  Unia, Poland



• Nitrofurazona Denver
  Denver, Argentina



• Nitrofurazona Lafedar
  Lafedar, Argentina



• Nitrofurazona Sertex
  Sertex, Argentina



• Nitrofurazone (Nitrofural and Butacaine (veterinary use))
  Med Pharmex, United States



• Nitrofurazone (veterinary use)
  Boehringer Ingelheim Vetmedica, United States; Bomac, New Zealand; Cross Vetpharm, United States; Med Pharmex, United States; Ranvet, Australia; Sparhawk, United States



• Nitromed
  Omedir, Argentina



• Polycin
  Nakornpatana, Thailand



• Rayonfur
  Materfarma, Portugal



• Solutio Furacilini
  Rigas farmaceitiska fabrika, Latvia



• Topifuran
  Medical Union Pharmaceuticals, Ethiopia



• Trofuran
  Roker, Peru

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Prop.INN	Proposed International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Gineflor

Gineflor may be available in the countries listed below.

Ingredient matches for Gineflor

Ibuprofen

Ibuprofen isobutanolamine (a derivative of Ibuprofen) is reported as an ingredient of Gineflor in the following countries:

• Italy

International Drug Name Search

Lukast

Lukast may be available in the countries listed below.

Ingredient matches for Lukast

Montelukast

Montelukast is reported as an ingredient of Lukast in the following countries:

• Colombia


• Guatemala

International Drug Name Search

Aciclovir Samenwerkende Apothekers

Aciclovir Samenwerkende Apothekers may be available in the countries listed below.

Ingredient matches for Aciclovir Samenwerkende Apothekers

Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Samenwerkende Apothekers in the following countries:

• Netherlands

International Drug Name Search

Luminaletas

Luminaletas may be available in the countries listed below.

Ingredient matches for Luminaletas

Phenobarbital

Phenobarbital is reported as an ingredient of Luminaletas in the following countries:

• Argentina


• Portugal


• Spain

International Drug Name Search

Citofolin

Citofolin may be available in the countries listed below.

Ingredient matches for Citofolin

Calcium Folinate

Calcium Folinate is reported as an ingredient of Citofolin in the following countries:

• Italy

International Drug Name Search

Hydrogalen

Hydrogalen may be available in the countries listed below.

Ingredient matches for Hydrogalen

Hydrocortisone

Hydrocortisone is reported as an ingredient of Hydrogalen in the following countries:

• Germany

International Drug Name Search

Ceftazidim

Ceftazidim may be available in the countries listed below.

Ingredient matches for Ceftazidim

Ceftazidime

Ceftazidime is reported as an ingredient of Ceftazidim in the following countries:

• Russian Federation


• Serbia

International Drug Name Search

Bactine

In the US, Bactine (lidocaine topical) is a member of the drug class topical anesthetics and is used to treat Anal Itching, Anesthesia, Burns - External, Hemorrhoids, Pain, Pruritus and Sunburn.

US matches:

• Bactine Liquid


• Bactine

Ingredient matches for Bactine

Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Bactine in the following countries:

• Canada

Lidocaine

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Bactine in the following countries:

• Canada

International Drug Name Search

Dexchlorpheniramine

Dosage Form: Oral Solution, USP 2 mg/5 mL

Rx only

Dexchlorpheniramine Description

Each 5 mL (teaspoonful) contains:

Dexchlorpheniramine Maleate, USP. . . . . . . . . . . . . . . 2 mg

Alcohol . . . . . . . . . . . . . . . . . . . . . . . . . not more than 7.0%

Dexchlorpheniramine Maleate, USP, an antihistamine agent, is a white, odorless crystalline powder that is freely soluble in water. The molecular formula is C16H19ClN2•C4H4O4, designated chemically as (+)-2-[p-Chloro-α-[2-(dimethylamino)ethyl]benzyl]pyridine maleate (1:1).

Inactive Ingredients: Citric Acid; Dehydrated Alcohol; FD&C Red No. 40; Glycerin; Liquid Sugar; Menthol; Methylparaben; Natural and Artificial Orange Juice Flavor; Propylene Glycol; Propylparaben and Purified Water. May also contain Sodium Citrate for pH adjustment. The pH range is between 5.0 and 6.5.

Dexchlorpheniramine - Clinical Pharmacology

Dexchlorpheniramine maleate is an antihistamine with anticholinergic (drying) and sedative side effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells.

Indications and Usage for Dexchlorpheniramine

Perennial and seasonal allergic rhinitis

Vasomotor rhinitis

Allergic conjunctivitis due to inhalant allergens and foods

Mild, uncomplicated allergic skin manifestations of urticaria and angioedema

Amelioration of allergic reactions to blood or plasma

Dermographism

As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Contraindications

Use in Newborn or Premature Infants

This drug should not be used in newborn or premature infants.

Use in Nursing Mothers

Because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers.

Use in Lower Respiratory Disease

Antihistamines should NOT be used to treat lower respiratory tract symptoms including asthma.

Antihistamines are also contraindicated in the following conditions:

  

Hypersensitivity to Dexchlorpheniramine maleate or other antihistamines of similar chemical structure

  

Monoamine oxidase inhibitor therapy (See Drug Interaction section)

Warnings

Antihistamines should be used with considerable caution in patients with:

  

Narrow angle glaucoma

  

Stenosing peptic ulcer

  

Pyloroduodenal obstruction

  

Symptomatic prostatic hypertrophy

  

Bladder neck obstruction

Use in Children

In infants and children, especially, antihistamines in overdosage may cause hallucinations, convulsions, or death.

As in adults, antihistamines may diminish mental alertness in children. In the young child, particularly, they may produce excitation.

Use in Pregnancy

Experience with this drug in pregnant women is inadequate to determine whether there exists a potential for harm to the developing fetus.

Use with CNS Depressants

Dexchlorpheniramine Maleate, USP has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.).

Use in Activities Requiring Mental Alertness

Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc.

Use in the Elderly (approximately 60 years or older)

Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients.

Precautions

Dexchlorpheniramine Maleate, USP has an atropine-like action and, therefore, should be used with caution in patients with:

  

History of bronchial asthma

  

Increased intraocular pressure

  

Hyperthyroidism

  

Cardiovascular disease

  

Hypertension

Drug Interaction

MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.

Adverse Reactions

1. General: Urticaria, drug rash, anaphylactic shock, photosensitivity, excessive perspiration, chills, dryness of mouth, nose and the throat.


2. Cardiovascular System: Hemolytic anemia, thrombocytopenia, agranulocytosis.


3. Hematologic System: Hemolytic anemia, thrombocytopenia, agranulocytosis.


4. Nervous System: Sedation, sleepiness, dizziness, disturbed coordination, fatigue, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, euphoria, paresthesias, blurred vision, diplopia, vertigo, tinnitus, acute labyrinthitis, hysteria, neuritis, convulsions.


5. G.I. System: Epigastric distress, anorexia, nausea, vomiting, diarrhea, constipation.


6. G.U. System: Urinary frequency, difficult urination, urinary retention, early menses.


7. Respiratory System: Thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness.

Overdosage

Antihistamine overdosage reactions may vary from central nervous system depression to stimulation. Stimulation is particularly likely in children. Atropine-like signs and symptoms—dry mouth, fixed, dilated pupils, flushing, and gastrointestinal symptoms may also occur.

If vomiting has not occurred spontaneously the patient should be induced to vomit. This is best done by having the patient drink a glass of water or milk after which the patient should be made to gag. Precautions against aspiration must be taken, especially in infants and children.

Saline cathartics, such as milk of magnesia, draw water into the bowel by osmosis and therefore, are valuable for their action in rapid dilution of bowel content.

Stimulants should not be used.

Vasopressors may be used to treat hypotension.

Dexchlorpheniramine Dosage and Administration

DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.

Recommended Dosage

Adults and Children 12 years of age and older: 2 mg (1 teaspoonful)

Children 6 to 11 years: 1 mg (1/2 teaspoonful)

Children 2 to 5 years: 0.5 mg (1/4 teaspoonful)

Doses are generally given every 4 to 6 hours.

How is Dexchlorpheniramine Supplied

Dexchlorpheniramine Maleate Oral Solution, USP 2 mg/5 mL is supplied as a red-orange colored, orange flavored liquid in the following sizes:

4 fl oz (118 mL)

16 fl oz (473 mL)

128 fl oz (3785 mL)

RECOMMENDED STORAGE

Store at 20 °–25 °C (68 °–77 °F) [See USP Controlled Room Temperature].

Dispense in a tight, light-resistant container as defined in the USP, with child-resistant closure.

Rx Only

Product No.: 8539

Manufactured By:

Morton Grove Pharmaceuticals, Inc.

Morton Grove, IL 60053

A50-8539-16

REV. 07-05

Dexchlorpheniramine MALEATE  Dexchlorpheniramine maleate  solution

Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 60432-539 Route of Administration ORAL DEA Schedule

INGREDIENTS Name (Active Moiety) Type Strength Dexchlorpheniramine Maleate (Dexchlorpheniramine Maleate) Active 2 MILLIGRAM  In 5 MILLILITER Citric Acid Inactive   Dehydrated Alcohol Inactive   FD&C Red No. 40 Inactive   Glycerin Inactive   Liquid Sugar Inactive   Menthol Inactive   Methylparaben Inactive   Natural and Artificial Orange Juice Flavor Inactive   Propylene Glycol Inactive   Propylparaben Inactive   Water Inactive   Sodium Citrate Inactive

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 60432-539-04 118 mL (MILLILITER) In 1 BOTTLE None 2 60432-539-16 473 mL (MILLILITER) In 1 BOTTLE None 3 60432-539-28 3785 mL (MILLILITER) In 1 BOTTLE None

Revised: 05/2006Morton Grove Pharmaceuticals, Inc.

More Dexchlorpheniramine resources

• Dexchlorpheniramine Side Effects (in more detail)
• Dexchlorpheniramine Use in Pregnancy & Breastfeeding
• Drug Images
• Dexchlorpheniramine Drug Interactions
• Dexchlorpheniramine Support Group
• 2 Reviews for Dexchlorpheniramine - Add your own review/rating

• Dexchlorpheniramine Controlled-Release Tablets MedFacts Consumer Leaflet (Wolters Kluwer)


• dexchlorpheniramine Concise Consumer Information (Cerner Multum)

Compare Dexchlorpheniramine with other medications

• Allergic Reactions
• Hay Fever